How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study Meeting Abstract


Authors: Mamtani, A.; Barrio, A.; King, T. A.; Plitas, G.; Van Zee, K. J.; Pilewskie, M.; El-Tamer, M. B.; Gemignani, M. L.; Heerdt, A. S.; Sclafani, L. M.; Sacchini, V.; Cody, H. S. 3rd; Morrow, M.
Abstract Title: How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study
Meeting Title: 69th Annual Cancer Symposium of the Society of Surgical Oncology (SSO)
Journal Title: Annals of Surgical Oncology
Volume: 23
Issue: 1 Suppl.
Meeting Dates: 2016 Mar 2-5
Meeting Location: Boston, MA
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2016-02-01
Start Page: S15
Language: English
ACCESSION: WOS:000368185000025
PROVIDER: wos
PUBMED: 26745989
DOI: 10.1245/s10434-015-5010-5
Notes: Meeting Abstract: 24 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrea Veronica Barrio
    134 Barrio
  2. Monica Morrow
    772 Morrow
  3. Kimberly J Van Zee
    293 Van Zee
  4. Hiram S Cody III
    242 Cody
  5. Mary L Gemignani
    218 Gemignani
  6. Virgilio Sacchini
    146 Sacchini
  7. Tari King
    186 King
  8. Alexandra S Heerdt
    110 Heerdt
  9. George Plitas
    107 Plitas
  10. Mahmoud B. El-Tamer
    105 El-Tamer
  11. Melissa Louise Pilewskie
    112 Pilewskie
  12. Anita   Mamtani
    65 Mamtani